The global coronary stents market was valued at USD 6.68 billion in 2024 and is expected to grow to USD 10.66 billion by 2032, reflecting a compound annual growth rate (CAGR) of 6.2% during the forecast period. In 2024, North America held the leading position in the market, accounting for a 33.08% share.

The coronary stents market plays a vital role in the treatment of coronary artery disease, offering minimally invasive solutions to restore blood flow in blocked or narrowed arteries. These small, expandable devices are widely used in angioplasty procedures to support arterial walls and reduce the risk of future blockages. With the increasing prevalence of cardiovascular diseases, changing lifestyles, and advancements in interventional cardiology, demand for coronary stents continues to grow. Innovations such as drug-eluting stents, bioresorbable stents, and improved stent delivery systems are enhancing clinical outcomes and patient recovery. As healthcare systems prioritize faster, safer, and more effective treatment options, the coronary stents market is poised for continued evolution and global expansion.

Continue reading for more details:

https://www.fortunebusinessinsights.com/industry-reports/coronary-stents-market-100065

Market Segmentation

By Product Type

• Bare-metal stents (BMS)

• Drug-eluting stents (DES)

• Bioresorbable vascular scaffolds (BVS)

By Material

• Metallic stents

• Polymer-based stents

• Hybrid stents

By End User

• Hospitals

• Ambulatory surgical centers

• Cardiac centers

• Specialty clinics

By Mode of Delivery

• Balloon-expandable stents

• Self-expanding stents

List Of Key Coronary Stents Market Companies Profiled:

• Medtronic (Ireland)

• Boston Scientific Corporation (U.S.)

• BIOTRONIK SE & Co. KG (Germany)

• Terumo Corporation (Japan)

• Abbott (U.S.)

• Relisys Medical Devices Limited. (India)

• Braun SE (Germany)

• MicroPort Scientific Corporation (China)

• Stentys S.A. (France)

• Meril Life Sciences Pvt. Ltd. (India)

Market Growth

• The coronary stents market is experiencing steady growth due to the increasing prevalence of coronary artery disease and rising demand for minimally invasive procedures.

• Advancements in stent technology, including drug-eluting stents and bioresorbable stents, are significantly boosting the coronary stents market.

• Growing geriatric population and a sedentary lifestyle are contributing to the rising incidence of heart-related disorders, fueling the coronary stents market.

• Increasing healthcare expenditure and the expansion of interventional cardiology procedures are supporting the growth of the coronary stents market.

• Favorable reimbursement policies and the availability of technologically advanced products are further enhancing the outlook for the coronary stents market.

Restraining Factors

• High cost of advanced stent systems may limit access in price-sensitive markets, affecting the coronary stents market.

• Risk of post-surgical complications such as restenosis and thrombosis continues to be a concern in the coronary stents market.

• Stringent regulatory approval processes can delay product launches in the coronary stents market.

• Limited healthcare infrastructure in rural and underserved regions can restrict the expansion of the coronary stents market.

• Availability of alternative treatments like coronary artery bypass grafting (CABG) may also pose a challenge for the coronary stents market.

Regional Analysis

North America

• Leads the coronary stents market due to high incidence of cardiovascular diseases, advanced healthcare systems, and early adoption of new technologies.

Europe

• The coronary stents market in Europe is growing steadily, supported by increasing awareness, healthcare funding, and the presence of key market players.

Asia Pacific

• Shows the fastest growth in the coronary stents market, driven by a large patient pool, improving medical infrastructure, and rising healthcare investment.

Latin America

• Demonstrates moderate growth in the coronary stents market due to expanding access to healthcare and the adoption of minimally invasive cardiac procedures.

Middle East & Africa

• The coronary stents market is gradually developing in this region, with growth supported by rising healthcare modernization and increasing prevalence of heart disease.